Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Letter: Praise for SAPHO Syndrome Article

Nils Erikson, MD, and Marcel Francis Kahn, MD  |  February 1, 2013

After reading your article on SAPHO, I may get a better treatment plan for my patient; thanks for drawing the attention of American College of Rheumatology members to an obscure condition that can vex patients and clinicians

ACR/ARHP Annual Meeting 2012: Cyclophosphamide and Rituximab Both Viable Treatment Options for ANCA-Associated Vasculitis

Mary Beth Nierengarten  |  February 1, 2013

Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists

ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints

Mary Beth Nierengarten  |  February 1, 2013

Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease

ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus

Susan Bernstein  |  February 1, 2013

Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE

Tail Insurance Protects Against Medical Malpractice Claims from Previous Jobs

Steven M. Harris, Esq.  |  February 1, 2013

Physicians who are resigning, retiring, switching jobs, or are terminated should consider tail insurance to cover malpractice claims brought after they’ve left their current employer

Make Critical Electronic Health Record Decisions Now to Avoid Penalties and Maximize Incentives

Staff  |  January 25, 2013

Rheumatology practices of all sizes are considering the most cost-efficient and effective ways to achieve Meaningful Use.

Aggressive Treatment of Inflammation Prevents Vision Loss in Patients with JIA-related Uveitis

Lara C. Pullen, PhD  |  January 24, 2013

A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.

New Hydrogel May Offer Promising Osteoarthritis Treatment

Kurt Ullman  |  January 16, 2013

A new hydrogel that can be stretched and is self-healing might become an effective ligament repair option in osteoarthritis (OA).

Gene to Block TNF Linked to Multiple Sclerosis but not Rheumatoid Arthritis

Kurt Ullman  |  January 16, 2013

A single nucleotide polymorphism (SNP) in the

TNFRSF1A

gene encoding the receptor for tumor necrosis factor (TNF) 1 is associated with multiple sclerosis (MS) but not rheumatoid arthritis (RA) or other autoimmune conditions.

Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients

Lara C. Pullen, PhD  |  January 2, 2013

In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.

  • « Previous Page
  • 1
  • …
  • 665
  • 666
  • 667
  • 668
  • 669
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences